CPLK
ActiveSummary
CPLK has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €257,908 and a net result of €119,758. Its solvency ranks better than 93% of 16666 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
Checked score
Score 2025
Axes · tick = 2024
Profitability100=
Solvency100=
Growth52
Track record94
Bankruptcy probability, 12 months
0.2%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €23,000 at 30 days acceptable
Liquidity ample (current ratio 23.61 against 9.5 in 2024; short-term debt: 4.1% and cash: 12.6% of total assets), and 4.1% of the assets are financed with debt.
Credit check for your own amount and term
Open the credit simulator : see how the verdict changes with amount, term and advance.
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies
more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
95.9%
Return on assets
44.5%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 22-07-2026, 9 days ahead of the deadline.
NBB · 2 filingsDeviation from the deadline
2025
9 d early
2024
9 d early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 2 accounts on average 9 days before the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
26-09-2026 today31-12-2026 close31-07-2027 deadline
History
Go further with this company
How much credit can you give this customer, and on what term?Credit simulator What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed Roughly what is this company worth?Value indication
Is this your company? See how customers and banks see it.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2025, micro schema
In the rankings
#9 company by equity in Trooz, Health and social work sector
Equity
€257,908▲ 85.6%
2024 · €138,983
Total assets
€268,985▲ 75.0%
2024 · €153,681
Net result
€119,758▼ 12.2%
2024 · €136,342
Working capital
€250,440▲ 101%
2024 · €124,887
Trend over the years
Click a name to add, emphasise or remove a line.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20242025
Operating result€178,363-€155,190▼ 13.0%
Net result€136,342-€119,758▼ 12.2%
Equity€138,983-€257,908▲ 85.6%
Total assets€153,681-€268,985▲ 75.0%
Debt€14,698-€11,077▼ 24.6%
Working capital€124,887-€250,440▲ 101%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result falls in 2025; 2025 is 13% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €268,985
Fixed assets
€7,468 ▼ 47.0%
Current assets
€261,517 ▲ 87.4%
Equity and liabilities €268,985
Equity
€257,908 ▲ 85.6%
Debt
€11,077 ▼ 24.6%
Debt's share of the balance-sheet total falls from 9.6% to 4.1%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€163,547▼
2024 · €191,351
Cash flow
€128,115▼
2024 · €149,330
Current ratio
23.61▲
2024 · 9.50
Debt to equity
0.04▼
2024 · 0.11
ROE
46.4%▼
2024 · 98.1%
ROA
44.5%▼
2024 · 88.7%
Interest coverage
536.24▼
2024 · 640.06
Debt ≤ 1 year
€11,077▼
2024 · €14,698
Income taxes
€35,804▼
2024 · €41,724
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
| Line | 2024 | 2025 | Change |
|---|---|---|---|
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €12,988 | €8,357 | ▼ 35.7% |
| Other operating charges640/8 | €1,077 | €583 | ▼ 45.8% |
| Gross operating margin9900 | €192,428 | €164,131 | ▼ 14.7% |
| Operating profit (loss)9901 | €178,363 | €155,190 | ▼ 13.0% |
| Financial income75/76B | €1 | €676 | ▲ 50,004% |
| Recurring financial income75 | €1 | €676 | ▲ 50,004% |
| Financial charges65/66B | €299 | €305 | ▲ 2.0% |
| Recurring financial charges65 | €299 | €305 | ▲ 2.0% |
| Profit (loss) for the period before taxes9903 | €178,066 | €155,562 | ▼ 12.6% |
| Income taxes67/77 | €41,724 | €35,804 | ▼ 14.2% |
| Profit (loss) for the period9904 | €136,342 | €119,758 | ▼ 12.2% |
| Profit (loss) for the period to be appropriated9905 | €136,342 | €119,758 | ▼ 12.2% |
| Line | 2024 | 2025 | Change |
|---|---|---|---|
| Assets | |||
| Total assets20/58 | €153,681 | €268,985 | ▲ 75.0% |
| Fixed assets21/28 | €14,096 | €7,468 | ▼ 47.0% |
| Tangible fixed assets22/27 | €14,096 | €7,468 | ▼ 47.0% |
| Furniture and vehicles24 | €14,096 | €7,468 | ▼ 47.0% |
| Current assets29/58 | €139,585 | €261,517 | ▲ 87.4% |
| Amounts receivable within one year40/41 | - | €643 | - |
| Other amounts receivable41 | - | €643 | - |
| Current investments50/53 | - | €150,000 | - |
| Cash at bank and in hand54/58 | €107,009 | €33,825 | ▼ 68.4% |
| Deferred charges and accrued income490/1 | €32,576 | €77,049 | ▲ 137% |
| Equity and liabilities | |||
| Total equity and liabilities10/49 | €153,681 | €268,985 | ▲ 75.0% |
| Equity10/15 | €138,983 | €257,908 | ▲ 85.6% |
| Contributions10/11 | €3,500 | €3,500 | = |
| Reserves13 | €135,483 | €254,408 | ▲ 87.8% |
| Distributable reserves133 | €135,483 | €254,408 | ▲ 87.8% |
| Amounts payable17/49 | €14,698 | €11,077 | ▼ 24.6% |
| Amounts payable within one year42/48 | €14,698 | €11,077 | ▼ 24.6% |
| Trade debts44 | €1,215 | €1,026 | ▼ 15.5% |
| Suppliers440/4 | €1,215 | €1,026 | ▼ 15.5% |
| Taxes, remuneration and social security45 | €6,884 | €9,975 | ▲ 44.9% |
| Taxes450/3 | €6,404 | €9,495 | ▲ 48.3% |
| Remuneration and social security454/9 | €480 | €480 | = |
| Other amounts payable47/48 | €6,599 | €76 | ▼ 98.9% |
| Line | 2024 | 2025 | Change |
|---|---|---|---|
| Profit (loss) for the period9904 | €136,342 | €119,758 | ▼ 12.2% |
| + Depreciation and write-downs630 | €12,988 | €8,357 | ▼ 35.7% |
| Operating cash flow (approximation) | €149,330 | €128,115 | ▼ 14.2% |
| Investment in fixed assets (approximation) | - | -€1,729 | - |
| Change in cash | - | -€73,184 | - |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
22-07
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
31-12
Financial
Liquidity doublescurrent ratio 23.61
Current ratio from 9.50 to 23.61; short-term debt falls from €14,698 to €11,077.
31-12
Financial
Equity above €200,000Eq €257,908 ▲85.6%
2 profitable years in a row build equity to €257,908.
22-07
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 2 acts read
About the unread acts
We know of 2 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Trooz · 1 establishment unit since 2023
Ground area
1,442 m²
Building footprint
647 m²
Volume, LiDAR
5,920 m³
2 parcels, Wallonia · tallest building 17.1 m, ±5 floors. Linked by address, not a title deed.
1 establishment unit
Rue de Hesbaye 185, 4000 Liège
since 20232.349.393.448
2 parcels
Wallonia
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 62040E0167/00D004 | Wallonia | 731 m² | 1 · 299 m² | 17.1 m · 1 fl. |
| 62802D0310/00A002 | Wallonia | 711 m² | 1 · 348 m² | 16.8 m · 5 fl. |
Linked by address, not proof of ownership
Good to know
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
DR. Sien Jongenelen
BE 0792.969.852
Antwerpen · Eq €257,940
Dr. Nelson Korir Anesthesie
BE 0788.865.960
Wommelgem · Eq €257,837
BRADLYK
BE 0797.271.605
Vorst · Eq €257,984
BITER CARACUDOVICI
BE 0734.967.020
Elsene · Eq €257,810
Dokter Mieke De Weweire
BE 0730.774.640
Tielt · Eq €258,051
Of 16,630 companies in sector 86220 we hold annual accounts for 7,981. 6,677 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded13-09-2023
Fiscal year end31-12
Activities, NACEBEL 2025
86220Specialist medical practice
Scores and ratios are computed by Checked and are not a credit decision.